UK plays part in Optos sales growth

Optos held a seminar in London last week to present the benefits of ultra-widefield (UWF) imaging in screening diabetic retinopathy and post its latest financial results.

All but three per cent of the Scottish retinal imaging firm’s sales were now outside the UK, but the company’s boss praised domestic eye screening services for diabetes patients.

Roy Davis, CEO of Optos, told Optician: ‘The UK is one of the leading places for diagnosis [of diabetes]. People look at it as a model for what they would look like.

‘Globally people are looking to do more screening because all healthcare budgets are under pressure.’